154 related articles for article (PubMed ID: 18425077)
1. Extrahepatic bile duct carcinoma with extensive intraepithelial spread: a clinicopathological study of 21 cases.
Nakanishi Y; Zen Y; Kawakami H; Kubota K; Itoh T; Hirano S; Tanaka E; Nakanuma Y; Kondo S
Mod Pathol; 2008 Jul; 21(7):807-16. PubMed ID: 18425077
[TBL] [Abstract][Full Text] [Related]
2. Carcinoma of the extrahepatic bile duct: mode of spread and its prognostic implications.
Yamaguchi K; Chijiiwa K; Saiki S; Shimizu S; Takashima M; Tanaka M
Hepatogastroenterology; 1997; 44(17):1256-61. PubMed ID: 9356836
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor II mRNA-binding protein 3 (IMP3) is a marker that predicts presence of invasion in papillary biliary tumors.
Sasaki M; Sato Y
Hum Pathol; 2017 Apr; 62():152-159. PubMed ID: 28089541
[TBL] [Abstract][Full Text] [Related]
4. Intraoperative frozen section diagnosis of bile duct margin for extrahepatic cholangiocarcinoma.
Shiraki T; Kuroda H; Takada A; Nakazato Y; Kubota K; Imai Y
World J Gastroenterol; 2018 Mar; 24(12):1332-1342. PubMed ID: 29599608
[TBL] [Abstract][Full Text] [Related]
5. Intraductal papillary neoplasms of the bile duct: stepwise progression to carcinoma involves common molecular pathways.
Schlitter AM; Born D; Bettstetter M; Specht K; Kim-Fuchs C; Riener MO; Jeliazkova P; Sipos B; Siveke JT; Terris B; Zen Y; Schuster T; Höfler H; Perren A; Klöppel G; Esposito I
Mod Pathol; 2014 Jan; 27(1):73-86. PubMed ID: 23828315
[TBL] [Abstract][Full Text] [Related]
6. Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm.
Nakanishi Y; Zen Y; Kondo S; Itoh T; Itatsu K; Nakanuma Y
Hum Pathol; 2008 Aug; 39(8):1153-61. PubMed ID: 18495210
[TBL] [Abstract][Full Text] [Related]
7. Well-differentiated adenocarcinoma, gastric foveolar type, of the extrahepatic bile ducts: A previously unrecognized and distinctive morphologic variant of bile duct carcinoma.
Albores-Saavedra J; Delgado R; Henson DE
Ann Diagn Pathol; 1999 Apr; 3(2):75-80. PubMed ID: 10196386
[TBL] [Abstract][Full Text] [Related]
8. Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma.
Sasaki R; Takeda Y; Funato O; Nitta H; Kawamura H; Uesugi N; Sugai T; Wakabayashi G; Ohkohchi N
World J Surg; 2007 Sep; 31(9):1788-1796. PubMed ID: 17647056
[TBL] [Abstract][Full Text] [Related]
9. Biliary cystic tumors with bile duct communication: a cystic variant of intraductal papillary neoplasm of the bile duct.
Zen Y; Fujii T; Itatsu K; Nakamura K; Konishi F; Masuda S; Mitsui T; Asada Y; Miura S; Miyayama S; Uehara T; Katsuyama T; Ohta T; Minato H; Nakanuma Y
Mod Pathol; 2006 Sep; 19(9):1243-54. PubMed ID: 16741522
[TBL] [Abstract][Full Text] [Related]
10. Invasive papillary carcinomas of the extrahepatic bile ducts: a clinicopathologic and immunohistochemical study of 13 cases.
Hoang MP; Murakata LA; Katabi N; Henson DE; Albores-Saavedra J
Mod Pathol; 2002 Dec; 15(12):1251-8. PubMed ID: 12481004
[TBL] [Abstract][Full Text] [Related]
11. An S100P-positive biliary epithelial field is a preinvasive intraepithelial neoplasm in nodular-sclerosing cholangiocarcinoma.
Nakanuma Y; Uchida T; Sato Y; Uesaka K
Hum Pathol; 2017 Feb; 60():46-57. PubMed ID: 27984121
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of matriptase in tumor stroma is a poor prognostic indicator of extrahepatic bile duct cancer.
Komatsubara T; Oshiro H; Sakuma Y; Sata N; Niki T; Fukushima N
Pathol Int; 2019 Feb; 69(2):86-93. PubMed ID: 30729623
[TBL] [Abstract][Full Text] [Related]
13. Recurrence of mucosal carcinoma of the bile duct, with superficial flat spread, 12 years after operation.
Nakanishi Y; Kondo S; Hirano S; Ambo Y; Tanaka E; Morikawa T; Itoh T
J Hepatobiliary Pancreat Surg; 2006; 13(4):355-8. PubMed ID: 16858550
[TBL] [Abstract][Full Text] [Related]
14. Confinement to the intrapancreatic bile duct is independently associated with a better prognosis in extrahepatic cholangiocarcinoma.
Ahn KS; Kang KJ; Kang YN; Kim YH; Kim TS
BMC Gastroenterol; 2016 Feb; 16():21. PubMed ID: 26911927
[TBL] [Abstract][Full Text] [Related]
15. Comparative clinicopathological study of biliary intraductal papillary neoplasms and papillary cholangiocarcinomas.
Fujikura K; Fukumoto T; Ajiki T; Otani K; Kanzawa M; Akita M; Kido M; Ku Y; Itoh T; Zen Y
Histopathology; 2016 Dec; 69(6):950-961. PubMed ID: 27410028
[TBL] [Abstract][Full Text] [Related]
16. Mass-forming intrahepatic cholangiocarcinoma presenting tumor growth in extrahepatic bile duct and superficial spreading.
Regimbeau JM; Panis Y; Nemeth J; Pocard M; de Claviere G; Soyer P; Valleur P
Hepatogastroenterology; 2003; 50(49):21-3. PubMed ID: 12629982
[TBL] [Abstract][Full Text] [Related]
17. [Intraductal papillary neoplasms of the bile duct (IPNB). Diagnostic criteria, carcinogenesis and differential diagnostics].
Schlitter AM; Klöppel G; Esposito I
Pathologe; 2013 Nov; 34 Suppl 2():235-40. PubMed ID: 24196621
[TBL] [Abstract][Full Text] [Related]
18. Spread of hilar cholangiocarcinomas via peribiliary gland network: a hither-to-unrecognized route of periductal infiltration.
Sato H; Nakanuma Y; Kozaka K; Sato Y; Ikeda H
Int J Clin Exp Pathol; 2013; 6(2):318-22. PubMed ID: 23330019
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological review of 61 patients with early bile duct cancer.
Cha JM; Kim MH; Lee SK; Seo DW; Lee SS; Lee JH; Lee SG; Jang SJ
Clin Oncol (R Coll Radiol); 2006 Nov; 18(9):669-77. PubMed ID: 17100152
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Impact of the Initial Postoperative CA19-9 Level in Patients with Extrahepatic Bile Duct Cancer.
Kato Y; Takahashi S; Gotohda N; Konishi M
J Gastrointest Surg; 2016 Aug; 20(8):1435-43. PubMed ID: 27250990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
